Liver Disease: Clinical Trials

19 trials for Liver Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 unknown, 2 terminated, 2 withdrawn. 19 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 119Completed 12, Unknown 3, Terminated 2, Withdrawn 2
Phase 24Completed 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Liver Disease: new trials by email Literature Review of Liver Disease trials Research Report on Liver Disease

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.
triopifexor, Placebo - Liver Disease
Phase 1CompletedNovartis Pharmaceuticals892020-05-292022-02-09
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
Azacitidine, Pevonedistat - Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
Phase 1CompletedTakeda172019-07-102024-09-05
Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients
Elafibranor - Hepatic Impairment, Liver Disease
Phase 1CompletedGenfit302018-12-122019-08-22
Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study
Caffeine citrate - Liver Disease
Phase 1WithdrawnUniversity of Birmingham2018-03-012018-04-19
Using Covered Stent of Diameter of 7mm in TIPS
the stent of diameter of 7mm, the stent of diameter of 8mm - Liver Disease
Phase 1UnknownBeijing Shijitan Hospital, Capital Medical University2162015-08-012015-09-04
The Effect of Probiotics on Non Alcoholic Fatty Liver Disease
BioFemale - Liver Disease
Phase 1TerminatedRabin Medical Center382013-02-012016-04-08
A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan
conivaptan hydrochloride - Liver Disease
Phase 1CompletedCumberland Pharmaceuticals172011-04-012014-05-02
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
Lovaza (omega-3-acid ethyl ester), Corn oil - Liver Disease, Short Bowel Syndrome
Phase 1 / Phase 2WithdrawnBoston Children's Hospital2011-01-012017-06-22
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
conventional therapy plus MenSC transplantation, Conventional therapy plus placebo treatment - Liver Cirrhosis, Fibrosis
Phase 1 / Phase 2UnknownS-Evans Biosciences Co., Ltd.502010-10-012012-06-07
A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941
ASP1941 - Liver Disease
Phase 1CompletedAstellas Pharma Inc162010-05-012010-10-07
Hepatocyte Matrix Implant Study
Hepatocyte matrix implantation - Liver Disease, Liver Cirrhosis
Phase 1UnknownBaermed102009-07-012011-04-12
Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function
conivaptan hydrochloride - Liver Disease, Hyponatremia
Phase 1CompletedCumberland Pharmaceuticals262009-02-012014-05-02
Hepatic Impairment Study
Sorafenib (Nexavar, BAY43-9006) - Liver Disease
Phase 1CompletedBayer452009-01-012014-11-03
A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
naproxcinod - Liver Disease
Phase 1CompletedNicOx242008-01-012011-06-17
Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
RTA 402 - Liver Disease
Phase 1 / Phase 2TerminatedBiogen162007-04-302025-05-30
A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency
Autologous Expanded CD34+ Haemopoietic cells - Liver Disease
Phase 1 / Phase 2CompletedImperial College London52006-01-012019-10-31
Health Behavior Feedback Study for Veterans With Hepatitis C
3 session brief intervention with health behavior feedback, treatment as usual - Alcoholism, Alcohol Abuse
Phase 1CompletedUniversity of Washington122003-12-012007-11-30
Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant
EBV-specific autologous CTL - Liver Disease, Lymphoproliferative Disorders
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)502002-05-012010-01-13
Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction
oxaliplatin - Liver Disease
Phase 1CompletedNational Cancer Institute (NCI)602000-07-012008-03-04

Narrower conditions

Liver Diseases (19)  ·  Liver Cirrhosis (2)  ·  Alcoholism (1)  ·  Digestive System Diseases (1)  ·  Fibrosis (1)  ·  Hepatitis C (1)  ·  Hyponatremia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoproliferative Disorders (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Renal Insufficiency (1)  ·  Short Bowel Syndrome (1)

Broader conditions

Digestive System Diseases (18)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Hemic and Lymphatic Diseases (2)  ·  Alcohol-Related Disorders (1)  ·  Blood-Borne Infections (1)  ·  Bone Marrow Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Chronic Disease (1)  ·  Communicable Diseases (1)  ·  Disease Attributes (1)  ·  Fatty Liver (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fibrosis (1)

Interventions

conivaptan (2)  ·  2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid (1)  ·  Azacitidine (1)  ·  Corn Oil (1)  ·  Fish Oils (1)  ·  Interferons (1)  ·  Omacor (1)  ·  Oxaliplatin (1)  ·  Sorafenib (1)  ·  Therapeutics (1)  ·  Ursodeoxycholic Acid (1)  ·  caffeine citrate (1)  ·  ipragliflozin (1)  ·  naproxen-n-butyl nitrate (1)  ·  pevonedistat (1)

Sponsors

Cumberland Pharmaceuticals (2)  ·  Astellas Pharma Inc (1)  ·  Baermed (1)  ·  Bayer (1)  ·  Beijing Shijitan Hospital, Capital Medical University (1)  ·  Biogen (1)  ·  Boston Children's Hospital (1)  ·  Genfit (1)  ·  Imperial College London (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  NicOx (1)  ·  Novartis Pharmaceuticals (1)  ·  Rabin Medical Center (1)  ·  S-Evans Biosciences Co., Ltd. (1)

Countries

United States (13)  ·  United Kingdom (2)  ·  China (1)  ·  Israel (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Art Wheeler, MD (2)  ·  Charlie Xiang, Professor (1)  ·  David Adams, MD (1)  ·  Hemda Weiss, M.D. (1)  ·  Jianli Xu, MD PhD (1)  ·  Nagy Habib, ChM FRCS (1)  ·  Tania M Davis Correale, PhD (1)  ·  Thomas C. Marbury, MD (1)  ·  Tom Jaksic, MD, PhD (1)

Results publications

PMID 42723205

NIH funding

2018 (1)